Home › Funds › BENDER ROBERT & ASSOCIATES › EOLS

BENDER ROBERT & ASSOCIATES position in EOLS

EVOLUS INC · Health Care

BENDER ROBERT & ASSOCIATES reported holding 25,070 shares of EOLS (EVOLUS INC) in its Q3 2026 13F filing — a position valued at US$201K, representing 0.04% of its reported portfolio and ranking #44 among its reported holdings. BENDER ROBERT & ASSOCIATES has disclosed EOLS holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)25.07K sh
Reported value held$200.56K
Portfolio Weight0.04%
First reportedQ3 2023
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BENDER ROBERT & ASSOCIATES's EOLS position evolved

BENDER ROBERT & ASSOCIATES first disclosed a stake in EOLS in Q3 2023 at 25,070 shares (US$229K). The position peaked in Q4 2024 at 25,070 shares, worth US$277K. Across 7 filings, BENDER ROBERT & ASSOCIATES held the position steady without any share-count change. The most recent filing (Q3 2026) shows 25,070 shares valued at US$201K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.07K $229.14K New
Q4 2023 25.07K $263.99K Hold
Q4 2024 25.07K $276.77K New
Q2 2025 25.07K $230.90K New
Q3 2025 25.07K $153.93K Hold
Q1 2026 25.07K $103.04K New
Q3 2026 25.07K $200.56K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EOLS and 13F data

EOLS (EVOLUS INC) is a Health Care company. 23 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$38.9M), BRAIDWELL LP (US$21.9M), Frazier Life Sciences Management, L.P. (US$18.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EOLS

All EOLS fund holders →

FAQ

How long has BENDER ROBERT & ASSOCIATES held EOLS?

BENDER ROBERT & ASSOCIATES has disclosed EOLS holdings in 7 of the last 13 reported quarters, going back to Q3 2023.

What is BENDER ROBERT & ASSOCIATES's current position in EOLS?

As of Q3 2026, BENDER ROBERT & ASSOCIATES holds 25.07K shares of EOLS (EVOLUS INC), valued at $200.56K, representing 0.04% of its reported portfolio and ranking #44.

Has BENDER ROBERT & ASSOCIATES been buying or selling EOLS?

In the latest 13F filing (Q3 2026), BENDER ROBERT & ASSOCIATES newly opened its position in EOLS. The position peaked in Q4 2024 at 25.07K shares.

Which other funds hold EOLS?

Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Frazier Life Sciences Management, L.P., among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.